• Muscle Cell Receptor Component Increases Myasthenia Gravis Treatment’s Punch, Study Shows
  • Phase 3 Trial Results Challenge the Long-held Notion of How Myasthenia Gravis Originates
  • Rare Disease Groups, Patients Differ on ‘Right to Try’ Bill Before US Congress
  • Comparative Trials Can Provide Valuable Data When Testing New Therapies for MG, Researchers Say
  • 2 Autoantibodies Identified as Potential New Biomarkers for Myasthenia Gravis, Researchers Say
  • Panel of Experts Propose Guidelines for Myasthenia Gravis Treatment and Care
  • Biological Agents Could Correct the Immune System Imbalance in MG, Study Suggests
  • NORD Fundraiser Sets 7,000-Mile ‘Bike, Run or Walk’ Goal for 7,000 Rare Diseases
  • Traditional Chinese Medicine Added to MG Therapies Seen to Carry Short-term Benefits, Study Reports
  • Researchers in France Seeking More Myasthenia Gravis Patients for Exercise Study
  • MG Patient Successfully Treated with Weekly Blood Purification Therapy, Case Report Says
  • Dosing Completed in Phase 1 Study of GTP-004 for Myasthenia Gravis Treatment Side Effects